Atlas Trials

Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI

Clinical trial NCT05661552 · COMPLETED

Trial details

NCT number
NCT05661552
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
Start date
2022-12-01
Primary completion
2025-02-05
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.